Physician profile
Anil Singh
NPI 1770587313
$2,026.07
in general payments reported to CMS, 2019-2025
21 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $245 · 2021: $420 · 2022: $427 · 2023: $263 · 2024: $326 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $458.85 | 2019-2025 | Farxiga, Wainua, Tagrisso |
| Merck Sharp & Dohme LLC | $199.89 | 2021-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $174.60 | 2022-2025 | Opsumit, Uptravi, Opsynvi |
| Janssen Pharmaceuticals, INC | $170.67 | 2020-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $169.90 | 2020-2024 | Jardiance |
| Pfizer INC. | $159.80 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $128.06 | 2021-2024 | Eliquis, Camzyos |
| Kiniksa Pharmaceuticals, LTD. | $80.83 | 2023 | Arcalyst |
| Medtronic Vascular, INC. | $69.69 | 2019 | |
| Boston Scientific Corporation | $57.51 | 2019-2024 | Watchman Access System, Latitude Communicator Power Supply |
| Novartis Pharmaceuticals Corporation | $52.86 | 2020-2023 | |
| Inspire Medical Systems, INC. | $46.30 | 2025 | Inspire |
| Esperion Therapeutics, INC. | $43.49 | 2024-2025 | Nexletol |
| Silk Road Medical, INC. | $43.19 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Kiniksa Pharmaceuticals International, Plc | $39.68 | 2024 | Arcalyst |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33.00 | 2024-2025 | Aveir, Jot Dx |
| Chiesi USA, INC. | $26.40 | 2019 | |
| Philips North America LLC | $21.24 | 2023 | |
| Irhythm Technologies, INC. | $17.23 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $16.91 | 2023 | Inpefa |
| Scpharmaceuticals INC. | $15.97 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anil Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.